炎症性肠病两年随访期间成本演变

数据集获取（Figshare）

• 源站标题：Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up
• DOI：10.1371/journal.pone.0142481
• 发布日期：2016-04-21
• 文件数：5 个
• 文件总体积：185.23 KB
• 源站页面：https://plos.figshare.com/articles/dataset/Evolution_of_Costs_of_Inflammatory_Bowel_Disease_over_Two_Years_of_Follow_Up/3196651

命令行下载

curl -L -o "S1 Table.DOCX" "https://ndownloader.figshare.com/files/5002432"
curl -L -o "S2 Table.DOCX" "https://ndownloader.figshare.com/files/5002435"
curl -L -o "S3 Table.DOCX" "https://ndownloader.figshare.com/files/5002444"
curl -L -o "S4 Table.DOCX" "https://ndownloader.figshare.com/files/5002450"
curl -L -o "S5 Table.DOCX" "https://ndownloader.figshare.com/files/5002459"

文件清单

• S1 Table.DOCX（69.26 KB）
• S2 Table.DOCX（69.26 KB）
• S3 Table.DOCX（13.34 KB）
• S4 Table.DOCX（14.08 KB）
• S5 Table.DOCX（19.29 KB）

文件总体积 185.23 KB（源站 API 实测）。

数据说明

Background
With the increasing use of anti-TNF therapy in inflammatory bowel disease (IBD), a shift of costs has been observed with medication costs replacing hospitalization and surgery as major cost driver. We aimed to explore the evolution of IBD-related costs over two years of follow-up.
Methods and Findings
In total 1,307 Crohn’'s disease (CD) patients and 915 ulcerative colitis (UC) patients were prospectively followed for two years by three-monthly web-based questionnaires. Changes of healthcare costs, productivity costs and out-of-pocket costs over time were assessed using mixed model analysis. Multivariable logistic regression analysis was used to identify costs drivers. In total 737 CD patients and 566 UC were included. Total costs were stable over two years of follow-up, with annual total costs of €7,835 in CD and €3,600 in UC. However, within healthcare costs, the proportion of anti-TNF therapy-related costs increased from 64% to 72% in CD (pConclusions
BD-related costs remained stable over two years. However, the proportion of anti-TNF-related healthcare costs increased, while hospitalization costs decreased. Factors associated with increased costs were penetrating disease course in CD and age <40 in UC.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0142481（source: https://plos.figshare.com/articles/dataset/Evolution_of_Costs_of_Inflammatory_Bowel_Disease_over_Two_Years_of_Follow_Up/3196651）。